[144] Qualys, Inc. SEC Filing

Rhea-AI Filing Summary

Qualys, Inc. (QLYS) Form 144 filed to report a proposed sale of 1,700 shares of common stock through Morgan Stanley Smith Barney LLC on 08/22/2025. The filing shows the shares were acquired on 06/07/2024 as restricted stock that vested under a registered plan and the acquisition was part of compensation. The aggregate market value of the proposed sale is listed as $229,313.00 and the company had 36,095,879 shares outstanding per the form. The filer indicates there were no other sales by the reporting person in the prior three months and provides the standard signature representation regarding material nonpublic information.

Insights

Securities Analyst

TL;DR: Small, routine insider sale of vested restricted shares; not material relative to outstanding shares.

The filing discloses a single proposed sale of 1,700 shares valued at $229,313 to be executed through Morgan Stanley Smith Barney LLC on 08/22/2025. The shares were acquired via restricted stock vesting on 06/07/2024 as compensation. Given the size of the proposed sale versus 36,095,879 shares outstanding, the transaction appears operationally routine and unlikely to move markets. The notice includes the required attestation that no undisclosed material adverse information is known to the seller.

Corporate Governance Expert

TL;DR: Filing follows Rule 144 disclosure for an executive sale of vested compensation; governance compliance appears standard.

The document documents compliance with Rule 144 for sale of shares issued as compensation. It identifies broker details and confirms no sales in the prior three months. The seller affirms lack of undisclosed material information and includes the standard legal attestation. There are no additional governance issues or related-party transactions disclosed in this filing text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1700	229313.00	36095879	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2024	Restricted stock vesting under a registered plan	Issuer			1700	06/07/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Qualys (QLYS) Form 144 disclose?

The form discloses a proposed sale of 1,700 common shares through Morgan Stanley Smith Barney LLC on 08/22/2025 with an aggregate market value of $229,313.00.

How were the 1,700 shares acquired according to the filing?

The shares were acquired on 06/07/2024 via restricted stock vesting under a registered plan and were issued as compensation.

Does the filing report other sales by the seller in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale in the Form 144?

The proposed sale lists Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004 as the broker.

What representation does the seller make about material information?

By signing, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed and notes Rule 10b5-1 plan language if applicable.